Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Recipharm financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.
Total Funding
$242.4 M
Revenue
KR705.5 M
FY, 2023
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| SEK | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|
| Revenue | 247.9M | 595.4M | 705.5M |
| General and administrative expense | 156.9M | 106.5M | 124.3M |
| Operating expense total | 547.8M | 941.9M | 1.1B |
| Depreciation and amortization | 32.4M | 30.9M | 31.4M |
| EBIT | (281.1M) | (207.3M) | (337.9M) |
| EBIT margin, % | -113.4% | -34.8% | -47.9% |
| Investment income | 25.5M | 102.3M | (8.6B) |
| Interest income | 2.1B | 3.5B | 6.7B |
| Interest expense | 1.6B | 3.4B | 6.5B |
| Pre tax profit | 119.6M | 79.2M | (8.6B) |
| Income tax expense | (219.4K) | (171.8M) | 171.8M |
| Net Income | 119.9M | 251.0M | (8.8B) |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |